語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Breast Cancer: From Bench to Personalized Medicine
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Breast Cancer: From Bench to Personalized Medicine/ edited by Saima Shakil Malik, Nosheen Masood.
其他作者:
Masood, Nosheen.
面頁冊數:
XVII, 536 p. 1 illus.online resource. :
Contained By:
Springer Nature eBook
標題:
Cancer Genetics and Genomics. -
電子資源:
https://doi.org/10.1007/978-981-19-0197-3
ISBN:
9789811901973
Breast Cancer: From Bench to Personalized Medicine
Breast Cancer: From Bench to Personalized Medicine
[electronic resource] /edited by Saima Shakil Malik, Nosheen Masood. - 1st ed. 2022. - XVII, 536 p. 1 illus.online resource.
Module 1_Overview of Breast Cancer -- Module 2_Cell and Molecular Biology of Breast Cancer-Diagnosis and Prognosis -- Module 3_Breast Cancer Treatment.
This book provides detailed information on the etiology, pathogenesis, diagnosis, prognosis, and treatment strategies for breast cancer. The first section of the book presents epidemiology, risk factors, histopathological, immunohistochemistry, and molecular subtypes of breast cancer based on the receptor status. It also discusses the association of breast cancer with other hormone-sensitive cancers. The second section of the book covers cover BRCA1 and BRCA2-associated breast carcinogenesis, early-stage progression of breast cancer, and noninvasive biomarkers for the early detection of breast cancer. It also discusses the role of epigenetic modifications and non-coding RNAs in breast cancer metastasis and explores these as the biomarkers and therapeutic targets for breast cancer therapy. Further, it discusses the role of fibrinolytic mechanisms and circulating tumor cells in breast cancer diagnosis, prognosis, and treatment. The book also provides an update on oral poly(ADP-ribose) polymerase (PARP) inhibitors to treat breast cancer. Finally, it offers potential new options for personalized therapies for breast cancer patients, including optimizing drug dosage and identifying genetic changes associated with cancer symptom occurrence and severity.
ISBN: 9789811901973
Standard No.: 10.1007/978-981-19-0197-3doiSubjects--Topical Terms:
1391074
Cancer Genetics and Genomics.
LC Class. No.: RC261-271
Dewey Class. No.: 571.978
Breast Cancer: From Bench to Personalized Medicine
LDR
:02814nam a22004095i 4500
001
1088878
003
DE-He213
005
20220514091817.0
007
cr nn 008mamaa
008
221228s2022 si | s |||| 0|eng d
020
$a
9789811901973
$9
978-981-19-0197-3
024
7
$a
10.1007/978-981-19-0197-3
$2
doi
035
$a
978-981-19-0197-3
050
4
$a
RC261-271
072
7
$a
MJCL
$2
bicssc
072
7
$a
MED062000
$2
bisacsh
072
7
$a
MJCL
$2
thema
082
0 4
$a
571.978
$2
23
082
0 4
$a
616.994
$2
23
245
1 0
$a
Breast Cancer: From Bench to Personalized Medicine
$h
[electronic resource] /
$c
edited by Saima Shakil Malik, Nosheen Masood.
250
$a
1st ed. 2022.
264
1
$a
Singapore :
$b
Springer Nature Singapore :
$b
Imprint: Springer,
$c
2022.
300
$a
XVII, 536 p. 1 illus.
$b
online resource.
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
347
$a
text file
$b
PDF
$2
rda
505
0
$a
Module 1_Overview of Breast Cancer -- Module 2_Cell and Molecular Biology of Breast Cancer-Diagnosis and Prognosis -- Module 3_Breast Cancer Treatment.
520
$a
This book provides detailed information on the etiology, pathogenesis, diagnosis, prognosis, and treatment strategies for breast cancer. The first section of the book presents epidemiology, risk factors, histopathological, immunohistochemistry, and molecular subtypes of breast cancer based on the receptor status. It also discusses the association of breast cancer with other hormone-sensitive cancers. The second section of the book covers cover BRCA1 and BRCA2-associated breast carcinogenesis, early-stage progression of breast cancer, and noninvasive biomarkers for the early detection of breast cancer. It also discusses the role of epigenetic modifications and non-coding RNAs in breast cancer metastasis and explores these as the biomarkers and therapeutic targets for breast cancer therapy. Further, it discusses the role of fibrinolytic mechanisms and circulating tumor cells in breast cancer diagnosis, prognosis, and treatment. The book also provides an update on oral poly(ADP-ribose) polymerase (PARP) inhibitors to treat breast cancer. Finally, it offers potential new options for personalized therapies for breast cancer patients, including optimizing drug dosage and identifying genetic changes associated with cancer symptom occurrence and severity.
650
2 4
$a
Cancer Genetics and Genomics.
$3
1391074
650
2 4
$a
Cancer Epidemiology.
$3
1396098
650
1 4
$a
Cancer Biology.
$3
1388882
650
0
$a
Cancer—Genetic aspects.
$3
1391073
650
0
$a
Cancer—Epidemiology.
$3
1396097
650
0
$a
Cancer.
$3
581034
700
1
$a
Masood, Nosheen.
$e
editor.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1318981
700
1
$a
Shakil Malik, Saima.
$e
editor.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1318982
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer Nature eBook
776
0 8
$i
Printed edition:
$z
9789811901966
776
0 8
$i
Printed edition:
$z
9789811901980
776
0 8
$i
Printed edition:
$z
9789811901997
856
4 0
$u
https://doi.org/10.1007/978-981-19-0197-3
912
$a
ZDB-2-SBL
912
$a
ZDB-2-SXB
950
$a
Biomedical and Life Sciences (SpringerNature-11642)
950
$a
Biomedical and Life Sciences (R0) (SpringerNature-43708)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入